by Angela Guess
Deborah Hirsch of HealthTechZone.com reports, “Cloudera announced that its co-founder and chief scientist, Jeff Hammerbacher will lead a project with Mount Sinai School of Medicine to use Cloudera’s big data platform to predict and understand the process and treatment of disease. ‘We are at the cutting edge of disease prevention and treatment, and the work that we will do together will reshape the landscape of our field,’ said Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Mount Sinai School of Medicine and executive vice president for academic affairs, The Mount Sinai Medical Center.”
Hirsch continues, “Together with Mount Sinai’s clinical and academic community, Hammerbacher will develop solutions designed for ‘scalable data analysis and multi-scale measurements in areas such as genotype, gene expression and organ health for medical research and discovery,’ providing real-time feedback and guidance for treatment to improve patient outcomes, the press release states. ‘We can improve healthcare delivery and treatment through new technology and acquired knowledge,’ said Eric Schadt, PhD, director of the Institute for Genomics and Multiscale Biology at Mount Sinai.”
